joint meeting of cmo and amr - nfp discussion and conclusions

13
eu2008.si Joint Meeting of CMO and AMR-NFP Discussion and Conclusions Marija Seljak, Director General of Public Health Ministry of Health

Upload: ted

Post on 09-Jan-2016

23 views

Category:

Documents


1 download

DESCRIPTION

Joint Meeting of CMO and AMR - NFP Discussion and Conclusions. Marija Seljak, Director General of Public Health Ministry of Health. A ntimicrobial resistance remains one of the serious European and global health problem - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

eu2008.si

Joint Meeting of CMO and AMR-NFP

Discussion and Conclusions

Marija Seljak, Director General of Public Health

Ministry of Health

Page 2: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

• Antimicrobial resistance remains one of the serious European and global health problem

• In most MS between 2001 and 2005 an increase of the burden of antimicrobial resistance can be observed (EARSS)

Page 3: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

• marked differences in AB use between EU countries and in the types of AB that are used

• consistent association between the level of use of certain AB and resistance to these AB has been reported confirming the suspected relationship between AB use and AMR in EU countries

Page 4: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

• Recommendations on prudent use of antimicrobials in human medicine adopted in 2001

• MS, European Commission and EU agencies (ECDC, EFSA, EMEA,…) have taken variety of actions

Page 5: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

•What are the areas of the Recommendations where the actions need to be improved?

Page 6: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

Need for…

• developing national strategy with translation to action plan

• ensuring ownership at the local level

Page 7: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

Need for…

• Setting up inter-sectorial mechanism, e.g. a national committee, involving all relevant stakeholders with the clear mandate and political support

Page 8: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

Need for…

• Strengthening surveillance systems and data quality on antimicrobial resistance, use of antimicrobial agents and healthcare-associated infections

Page 9: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

Need for…

• Promoting good hygiene practices for the control of the transmission multidrug resistance bacteria

Page 10: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

Need for…

• Promoting prudent use of antibiotics through awareness campaigns with credible, scientifically based messages and actions, aimed at the practitioners and general public and include information about the risk of self-medication

Page 11: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

Need for at EU level…

• Follow – up on the implementation of Council Recommendations

• Continue with “Health in all policies approach” in this area through EU initiatives

Page 12: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

Need for at EU level

• Continue with activities within the ECDC in this area (country visits, recommendations, scientific work, surveillance)

• Exchange of best practices among MS• Antibiotic Awareness Day

Page 13: Joint Meeting of CMO and  AMR - NFP Discussion and Conclusions

eu2008.si

HVALA!THANK YOU!